SGRO.L
SEGRO Plc
$997.40
+15.40
(+1.57%)
Mkt Cap
13.49B
Volume
7,863,133
52W Range
603-997.4
Sector
Real Estate
Beta
1.14
EPS (TTM)
0.41
P/E Ratio
2432.68
Revenue (TTM)
726.00M
Rev Growth (5Y)
+11.0%
EPS Growth (5Y)
-19.9%
Company Description
Operating as a prominent UK Real Estate Investment Trust (REIT), SEGRO excels in the acquisition, stewardship, and construction of contemporary warehouse and light industrial facilities. The company oversees an expansive portfolio, valued at a substantial £13.3 billion, encompassing approximately 8.1 million square meters (88 million square feet) of space. This extensive real estate serves a broad spectrum of clients across numerous industry sectors. Its strategically located assets are positioned near key urban centers and vital transport junctions, extending across the United Kingdom and into seven additional European nations.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 726.00M | 675.00M | 749.00M | 669.00M | 546.00M | 431.70M | 432.50M | 369.00M | 297.20M | 244.10M | 227.70M | 226.90M |
| Net Income | 551.00M | 594.00M | (253.00M) | (1.93B) | 4.06B | 1.43B | 857.90M | 1.06B | 952.70M | 417.70M | 682.50M | 682.00M |
| EPS | 0.41 | 0.45 | -0.21 | -1.60 | 3.39 | 1.24 | 0.79 | 1.05 | 0.98 | 0.54 | 0.92 | 0.92 |
| Free Cash Flow | 367.00M | 306.00M | 402.00M | 204.00M | 304.00M | 194.40M | 207.60M | 198.70M | (26.30M) | 97.70M | 85.60M | 118.80M |
| FCF / Share | 0.27 | 0.23 | 0.33 | 0.17 | 0.25 | 0.17 | 0.19 | 0.20 | -0.03 | 0.13 | 0.11 | 0.16 |
| Operating CF | 396.00M | 330.00M | 431.00M | 213.00M | 311.00M | 199.30M | 210.30M | 200.30M | (24.30M) | 101.20M | 87.70M | 123.00M |
| Total Assets | 18.18B | 17.57B | 17.31B | 17.35B | 17.78B | 12.67B | 10.08B | 9.17B | 7.94B | 6.11B | 5.56B | 4.81B |
| Total Debt | 5.03B | 4.68B | 5.42B | 4.96B | 3.48B | 2.50B | 2.02B | 2.24B | 2.06B | 1.63B | 1.82B | 1.70B |
| Cash & Equiv | 111.00M | 292.00M | 315.00M | 162.00M | 45.00M | 89.00M | 132.50M | 66.50M | 109.30M | 32.00M | 16.40M | 23.80M |
| Book Value | 12.27B | 12.05B | 10.90B | 11.37B | 13.44B | 9.66B | 7.68B | 6.56B | 5.59B | 4.18B | 3.49B | 2.89B |
| Return on Equity | 0.04 | 0.05 | -0.02 | -0.17 | 0.30 | 0.15 | 0.11 | 0.16 | 0.17 | 0.10 | 0.20 | 0.24 |
| Metric | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 | Q4 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 375.00M | 175.50M | 348.00M | 327.00M | 407.00M | 342.00M | 339.00M | 330.00M | 300.00M | 246.00M | 233.60M | 198.10M |
| Net Income | 304.00M | 123.50M | 374.00M | 220.00M | (230.00M) | (23.00M) | (3.26B) | 1.33B | 2.74B | 1.32B | 1.21B | 216.20M |
| EPS | 0.22 | 0.09 | 0.28 | 0.17 | -0.19 | -0.02 | -2.70 | 1.11 | 2.28 | 1.10 | 1.02 | 0.20 |
| Free Cash Flow | 224.00M | 71.50M | 174.00M | 132.00M | 222.00M | 180.00M | 44.00M | 160.00M | 164.00M | 140.00M | 111.90M | 82.50M |
| FCF / Share | 0.17 | 0.05 | 0.13 | 0.10 | 0.18 | 0.15 | 0.04 | 0.13 | 0.14 | 0.12 | 0.09 | 0.07 |
| Operating CF | 245.00M | 75.50M | 189.00M | 141.00M | 243.00M | 188.00M | 50.00M | 163.00M | 166.00M | 145.00M | 114.80M | 84.50M |
| Total Assets | 18.18B | 17.81B | 17.57B | 17.57B | 17.31B | 17.48B | 17.35B | 19.83B | 17.78B | 13.92B | 12.67B | 11.13B |
| Total Debt | 5.03B | 4.96B | 4.68B | 4.98B | 5.42B | 5.23B | 4.96B | 3.92B | 3.48B | 2.35B | 2.50B | 2.00B |
| Cash & Equiv | 111.00M | 141.00M | 292.00M | 546.00M | 376.00M | 103.00M | 162.00M | 91.00M | 45.00M | 78.00M | 89.00M | 203.40M |
| Book Value | 12.27B | 12.07B | 12.05B | 11.83B | 10.90B | 11.20B | 11.37B | 14.70B | 13.44B | 10.78B | 9.66B | 8.54B |
| Return on Equity | 0.02 | 0.01 | 0.03 | 0.02 | -0.02 | -0.00 | -0.29 | 0.09 | 0.20 | 0.12 | 0.13 | 0.03 |
SGRO.L News
SEGRO jumps after board agrees to recommend Prologis deal
Scancell to join Nasdaq through Neuphoria merger and $89 million funding package
American Rare Earths strengthens board with veteran Wyoming mine builder ahead of planned Nasdaq listing
Prologis 'clearly' can make a higher offer to secure Segro deal, analysts say
Coiled Therapeutics appoints biotech veteran Craig Tooman to board
SEGRO rejects £12.6bn all-share bid from Prologis
FTSE 100: European stocks dragged down as dollar rallies and gold exert pull